New study mapping care pathways for patients with #hipfracture in LMICs in South Asia. Insights on pre-hospital transport, time to admission, time to surgery, time to weightbearing, multidisciplinary care, and patient discharge + follow-up @BoneJointOpen https://t.co/7AS0D7Nbgk

NEW: Service availability and readiness for hip fracture care in LMICs in South and Southeast Asia @BoneJointOpen FERMAT collaborators and the Global Fragility Fracture Network Hip Fracture Audit Special Interest Group @Oxford_Trauma @ndorms @FF_Network

Prof Costa introduces an article on the opportunities and challenges of international orthopaedic trials in @BoneJointJ @ndorms @HIPCARE_study #orthotwitter

What exactly is a clinical trial? https://t.co/TLyHALXnQK First in what I hope will be a series of short and accessible articles on clinical trials. More to follow.

See our very own Prof Matt Costa introducing 'International orthopaedic trials global reach for a global burden of disease' in @BoneJointJ https://t.co/ySol8ry69V Read the full article here:

"With rapidly ageing populations in Asia, the number of patients at risk of hip fractures is increasing. Now more than ever, we need to find ways to improve outcomes and restore quality of life, while also making savings on health system costs." https://t.co/t6frjn9zjd

Very happy that HIPCARE is one of the projects awarded funding from the @NIHRresearch Research and Innovation for Global Health Transformation (RIGHT) programme: https://t.co/UN3XxDDq7P